Texas Yale Capital Corp’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Hold |
10,000
| – | – | ﹤0.01% | 462 |
|
|
2025
Q1 | $7.2K | Hold |
10,000
| – | – | ﹤0.01% | 451 |
|
|
2024
Q4 | $10.3K | Buy |
+10,000
| New | +$10.3K | ﹤0.01% | 459 |
|
|
2024
Q3 | – | Sell |
-10,000
| Closed | -$13K | – | 462 |
|
|
2024
Q2 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 438 |
|
|
2024
Q1 | $17.2K | Hold |
10,000
| – | – | ﹤0.01% | 440 |
|
|
2023
Q4 | $14.7K | Hold |
10,000
| – | – | ﹤0.01% | 431 |
|
|
2023
Q3 | $12.1K | Hold |
10,000
| – | – | ﹤0.01% | 420 |
|
|
2023
Q2 | $14.5K | Hold |
10,000
| – | – | ﹤0.01% | 439 |
|
|
2023
Q1 | $14.5K | Hold |
10,000
| – | – | ﹤0.01% | 448 |
|
|
2022
Q4 | $17.3K | Buy |
+10,000
| New | +$17.3K | ﹤0.01% | 449 |
|